Pharmacy Acquisition Finance
How Doulton Bridging Finance arranged £600,000 of pharmacy acquisition finance for a GPhC-registered pharmacist to acquire a second NHS-dispensing community pharmacy.
“The first pharmacy took me five years to own outright. The second one I acquired in seven weeks with Doulton's help. The specialist pharmacy lenders they introduced us to understood NHS contracts in a way no bank ever had.”
The Scenario
A GPhC-registered pharmacist and sole owner of an NHS-dispensing community pharmacy in Leicestershire, generating annual NHS dispensing income of £520,000 and EPS prescription volumes of 8,200 items per month, had been approached by the executor of a recently deceased independent pharmacist's estate about acquiring the deceased pharmacist's business: a second NHS-dispensing pharmacy four miles away with annual NHS income of £480,000 and a loyal patient register of 4,800 registered patients.
The Challenge
The agreed acquisition price was £720,000, comprising the dispensing goodwill and NHS contract (valued on a per-item basis at £480,000) and the leasehold fit-out and equipment (£240,000). The buyer had £120,000 available from retained earnings in the first pharmacy, leaving a balance of £600,000 to be financed. Two high-street banks were familiar with pharmacy lending in principle but struggled to underwrite the specific transaction, in particular the goodwill component valued on NHS dispensing volume, which requires sector-specific knowledge to assess accurately. One bank required 18 months of accounts from the acquired pharmacy (available from the estate) but could not get comfortable with NHS contract transfer risk; the other offered only £350,000, which was insufficient. The buyer's accountant, who specialised in pharmacy practice accounts, recommended Doulton Bridging Finance.
The Solution
Pharmacy acquisition finance is a specialist area with a small number of lenders who genuinely understand how to value NHS dispensing goodwill, assess NHS contract transfer risk, and structure lending around the NHSBSA payment cycle. We introduced the buyer to two specialist healthcare and pharmacy lenders, both with dedicated pharmacy acquisition teams who understood the GPhC registration transfer process, the NHSBSA contract assignment procedure, and the patient register as a proxy for ongoing dispensing volume. The preferred lender assessed the transaction on the combined NHS income of both pharmacies, a combined NHSBSA income of £1,000,000 per annum, and structured the £600,000 over 10 years at 7.1% fixed for the first five years. The DSCR on the combined operation was 2.8x, well within the lender's threshold. A condition of the facility was that the buyer had obtained CQC advice on the regulatory requirements for ownership transfer, which the buyer had already done.
The Deal Structure
| Loan Amount | £600,000 |
|---|---|
| Acquisition Price | £720,000 (goodwill + fit-out) |
| Buyer Contribution | £120,000 (16.7%) |
| Rate | 7.1% fixed for 5 years, then lender SVR |
| Term | 10 years, capital and interest |
| Monthly Repayment | £6,985 |
| Security | Debenture over both pharmacy businesses + personal guarantee |
| Underwriting Basis | Combined NHS income from both pharmacies |
The Outcome
Legal completion and NHS contract transfer took place seven weeks after instruction. GPhC registration transfer was completed concurrently by the buyer's solicitor, with no gap in the pharmacy's operational status, and NHSBSA continued payments without interruption following the ownership change. In the 12 months following acquisition, the buyer introduced an extended dispensing service and a minor ailment scheme referral pathway with two local GP surgeries, lifting dispensing volumes at the acquired pharmacy from 8,200 to 9,600 items per month by month nine. The buyer has since engaged Doulton Bridging Finance to explore options for a third site, with the refinanced combined business expected to support additional acquisition lending from the end of year two.